Real-world impact of bridging therapy on outcomes of ide-cel for myeloma in the U.S. Myeloma Immunotherapy Consortium

Autor:	Aimaz Afrough, Hamza Hashmi, Doris K. Hansen, Surbhi Sidana, Chul Ahn, Lauren C. Peres, Danai Dima, Ciara L. Freeman, Omar Castaneda Puglianini, Mehmet H. Kocoglu, Shebli Atrash, Peter M. Voorhees, Leyla Shune, Joseph P. McGuirk, Gary Simmons, Douglas W. Sborov, James A. Davis, Gurbakhash Kaur, Aishwarya Sannareddy, Christopher J. Ferreri, Mahmoud R. Gaballa, Scott Goldsmith, Omar Nadeem, Shonali Midha, Charlotte B. Wagner, Frederick L. Locke, Krina K. Patel, Jack Khouri, Larry D. Anderson, Yi Lin
Jazyk:	angličtina
Rok vydání:	2024
Předmět:	Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282
Zdroj:	Blood Cancer Journal, Vol 14, Iss 1, Pp 1-5 (2024)
Druh dokumentu:	article
ISSN:	2044-5385
DOI:	10.1038/s41408-024-00993-0
Databáze:	Directory of Open Access Journals
Externí odkaz:	https://doaj.org/article/3e7b6b54104143d6819770a8ea596373 Zobrazit plný text záznamu Full text from SpringerLink View record in DOAJ